Journal of General Virology, Vol 80, 1241-1251, Copyright © 1999 by Society for General Microbiology

ARTICLES

Coreceptor usage of BOB/GPR15 and Bonzo/STRL33 by primary isolates of human immunodeficiency virus type 1

S Pohlmann, M Krumbiegel and F Kirchhoff
Institute for Clinical and Molecular Virology, University of Erlangen-Nurnberg, Schlossgarten 4, 91054 Erlangen, Germany

Primary isolates of human and simian immunodeficiency viruses (HIV and SIV) use the chemokine receptor CCR5, in association with CD4, as coreceptor. During AIDS progression, HIV-1 and HIV-2 often adapt to use additional cofactors, particularly CXCR4. In contrast, SIV isolates do not use CXCR4, but other coreceptors such as BOB/GPR15 and Bonzo/STRL33. Only limited information is currently available on usage of BOB/GPR15 and Bonzo/STRL33 by HIV-1. Therefore, we investigated a panel of gp160 clones from 15 primary isolates, representing 5 different subtypes, for utilization of these cofactors. The majority of HIV-1 envelopes mediated entry into BOB/GPR15-expressing cells, albeit often with low efficiency. Usage of Bonzo/STRL33 was less common and usually inefficient. To investigate if HIV-1 entry via these orphan receptors is sufficient to allow virus replication, 15 uncloned primary HIV-1 isolates and 7 molecular clones were used to infect target cells expressing CD4 and Bonzo/STRL33 or BOB/GPR15. Three primary isolates and two molecular clones replicated efficiently in cells expressing BOB/GPR15. Two of these isolates were X4-tropic, two were R5X4-tropic and one was R5-tropic. In contrast, none of the HIV-1 variants showed significant levels of replication in Bonzo/STRL33-expressing cells. Our data show that some HIV-1 isolates of different genetic subtype and of different biological phenotype use BOB/GPR15 for productive infection and suggest that this cofactor may play a role in HIV-1 pathogenesis and transmission.

This article has been cited by other articles:

				S. Hatse, D. Huskens, K. Princen, K. Vermeire, G. J. Bridger, E. De Clercq, M. M. Rosenkilde, T. W. Schwartz, and D. Schols Modest Human Immunodeficiency Virus Coreceptor Function of CXCR3 Is Strongly Enhanced by Mimicking the CXCR4 Ligand Binding Pocket in the CXCR3 Receptor J. Virol., April 1, 2007; 81(7): 3632 - 3639. [Abstract] [Full Text] [PDF]

				T. Cilliers, J. Nhlapo, M. Coetzer, D. Orlovic, T. Ketas, W. C. Olson, J. P. Moore, A. Trkola, and L. Morris The CCR5 and CXCR4 Coreceptors Are Both Used by Human Immunodeficiency Virus Type 1 Primary Isolates from Subtype C J. Virol., April 1, 2003; 77(7): 4449 - 4456. [Abstract] [Full Text] [PDF]

				J. Munch, L. Standker, S. Pohlmann, F. Baribaud, A. Papkalla, O. Rosorius, R. Stauber, G. Sass, N. Heveker, K. Adermann, et al. Hemofiltrate CC Chemokine 1[9-74] Causes Effective Internalization of CCR5 and Is a Potent Inhibitor of R5-Tropic Human Immunodeficiency Virus Type 1 Strains in Primary T Cells and Macrophages Antimicrob. Agents Chemother., April 1, 2002; 46(4): 982 - 990. [Abstract] [Full Text] [PDF]

				F. Clayton, D. P. Kotler, S. K. Kuwada, T. Morgan, C. Stepan, J. Kuang, J. Le, and J. Fantini Gp120-Induced Bob/GPR15 Activation : A Possible Cause of Human Immunodeficiency Virus Enteropathy Am. J. Pathol., November 1, 2001; 159(5): 1933 - 1939. [Abstract] [Full Text] [PDF]

				S. S. Kim, X. J. You, M.-E. Harmon, J. Overbaugh, and H. Fan Use of Helper-Free Replication-Defective Simian Immunodeficiency Virus-Based Vectors To Study Macrophage and T Tropism: Evidence for Distinct Levels of Restriction in Primary Macrophages and a T-Cell Line J. Virol., March 1, 2001; 75(5): 2288 - 2300. [Abstract] [Full Text]

				R. Sabbe, G. R. Picchio, C. Pastore, O. Chaloin, O. Hartley, R. Offord, and D. E. Mosier Donor- and Ligand-Dependent Differences in C-C Chemokine Receptor 5 Reexpression J. Virol., January 15, 2001; 75(2): 661 - 671. [Abstract] [Full Text]

				Y.-j. Zhang, B. Lou, R. B. Lal, A. Gettie, P. A. Marx, and J. P. Moore Use of Inhibitors To Evaluate Coreceptor Usage by Simian and Simian/Human Immunodeficiency Viruses and Human Immunodeficiency Virus Type 2 in Primary Cells J. Virol., August 1, 2000; 74(15): 6893 - 6910. [Abstract] [Full Text]

				M. Sharron, S. Pohlmann, K. Price, E. Lolis, M. Tsang, F. Kirchhoff, R. W. Doms, and B. Lee Expression and coreceptor activity of STRL33/Bonzo on primary peripheral blood lymphocytes Blood, July 1, 2000; 96(1): 41 - 49. [Abstract] [Full Text] [PDF]

				S. Pöhlmann, B. Lee, S. Meister, M. Krumbiegel, G. Leslie, R. W. Doms, and F. Kirchhoff Simian Immunodeficiency Virus Utilizes Human and Sooty Mangabey but Not Rhesus Macaque STRL33 for Efficient Entry J. Virol., June 1, 2000; 74(11): 5075 - 5082. [Abstract] [Full Text]

				B. Schramm, M. L. Penn, R. F. Speck, S. Y. Chan, E. De Clercq, D. Schols, R. I. Connor, and M. A. Goldsmith Viral Entry through CXCR4 Is a Pathogenic Factor and Therapeutic Target in Human Immunodeficiency Virus Type 1 Disease J. Virol., January 1, 2000; 74(1): 184 - 192. [Abstract] [Full Text]